ReviewAnnual review of medicine2017
Noninvasive Prenatal DNA Testing: The Vanguard of Genomic Medicine.
Review in Annual review of medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed.
- Early Detection of Major Fetal Structural Anomalies in the First Trimester: A Retrospective Single-Center Study in an Unselected Population.Journal of clinical medicine · 2026Article
- The Function of Non-invasive Prenatal Testing (NIPT) Request Forms in the Australian Context.Health care analysis : HCA : journal of health philosophy and policy · 2025Article
- Noninvasive prenatal screening in a pregnant woman with a history of stem cell transplant from a male donor: A case report and literature review.Molecular genetics & genomic medicine · 2024Review
- Supporting patient decision-making in non-invasive prenatal testing: a comparative study of professional values and practices in England and France.BMC medical ethics · 2024Article
- Non-invasive prenatal testing (NIPT): is routinization problematic?BMC medical ethics · 2023Article
- Non-invasive prenatal testing in Germany: a unique ethical and policy landscape.European journal of human genetics : EJHG · 2023Article
- Clinician views and experiences of non-invasive prenatal genetic screening tests in Australia.The Australian & New Zealand journal of obstetrics & gynaecology · 2022Article
- Feto-maternal microchimerism: Memories from pregnancy.iScience · 2022Review
- Case Report: Two cases of apparent discordance between non-invasive prenatal testing (NIPT) and amniocentesis resulting in feto-placental mosaicism of trisomy 21. Issues in diagnosis, investigation and counselling.Frontiers in genetics · 2022Article
- The effect of maternal body mass index and gestational age on circulating trophoblast yield in cell-based noninvasive prenatal testing.Prenatal diagnosis · 2020Article
- Liquid Biopsy Applications in the Clinic.Molecular diagnosis & therapy · 2020Review
- Fetal fraction and noninvasive prenatal testing: What clinicians need to know.Prenatal diagnosis · 2020Review
- Just choice: a Danielsian analysis of the aims and scope of prenatal screening for fetal abnormalities.Medicine, health care, and philosophy · 2019Article
- A Capabilities Approach to Prenatal Screening for Fetal Abnormalities.Health care analysis : HCA : journal of health philosophy and policy · 2019Article
- Noninvasive prenatal diagnosis of β-thalassemia by relative haplotype dosage without analyzing proband.Molecular genetics & genomic medicine · 2019Article
- 'Small cost to pay for peace of mind': Women's experiences with non-invasive prenatal testing.The Australian & New Zealand journal of obstetrics & gynaecology · 2019Article
- Termination of pregnancy for fetal anomalies: Parents' preferences for psychosocial care.Prenatal diagnosis · 2019Article
- Review
- [France and Great-Britain at the age of genomic medicine: new ethical challenges in reproductive medicine].Medecine sciences : M/S · 2019Article
- Feto-Maternal Microchimerism: The Pre-eclampsia Conundrum.Frontiers in immunology · 2019Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Noninvasive prenatal DNA testing is the vanguard of genomic medicine. In only four years, this screening test has revolutionized prenatal care globally and opened up new prospects for personalized medicine for the fetus. There are widespread implications for increasing the scope of human genetic variation that can be detected before birth, and for discovering more about maternofetal and placental biology. These include an urgent need to develop pretest education for all pregnant women and consistent post-test management recommendations for those with discordant test results. The reduction in invasive testing has had downstream effects on specialist training and caused many countries to re-examine their national approaches to prenatal screening. Finally, the accumulating datasets of genomic information on pregnant women and their fetuses raise ethical issues regarding consent for future data mining and intellectual property.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.